Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Change in Receivables (2020 - 2023)

Barinthus Biotherapeutics (BRNS) has disclosed Change in Receivables for 4 consecutive years, with -$194000.0 as the latest value for Q3 2023.

  • For Q3 2023, Change in Receivables rose 98.21% year-over-year to -$194000.0; the TTM value through Jun 2024 reached -$194000.0, up 98.85%, while the annual FY2023 figure was -$5.8 million, 199.43% down from the prior year.
  • Change in Receivables hit -$194000.0 in Q3 2023 for Barinthus Biotherapeutics, up from -$645000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $18.4 million in Q1 2022 and bottomed at -$10.9 million in Q3 2022.
  • Average Change in Receivables over 4 years is -$67000.0, with a median of -$284000.0 recorded in 2021.
  • On a YoY basis, Change in Receivables climbed as much as 8923.08% in 2022 and fell as far as 181200.0% in 2022.
  • Barinthus Biotherapeutics' Change in Receivables stood at $448000.0 in 2020, then crashed by 116.29% to -$73000.0 in 2021, then crashed by 350.68% to -$329000.0 in 2022, then soared by 41.03% to -$194000.0 in 2023.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$194000.0, -$645000.0, and -$5.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.